A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Rybelsus (semaglutide) and Ozempic (semaglutide) are prescription drugs used to treat type 2 diabetes. Rybelsus comes as an oral tablet, while Ozempic comes as an injectable liquid solution.

Rybelsus and Ozempic are brand-name medications with the same active ingredient: semaglutide. Semaglutide, a GLP-1 agonist, ...

This semaglutide pill mimics the gut hormone GLP-1 in the same way the injections do, and it must be taken daily compared with Ozempic’s once-weekly injections. Rybelsus is approved for type 2 ...

It would become the first add-on indication for Rybelsus, which was originally approved for Type 2 diabetes in 2019 but has been overshadowed by the booming mainstream popularity of Ozempic and ...

GLP-1 drugs include Ozempic and Rybelsus, both of which have been approved by the Food and Drug Administration to treat diabetes. They also include Saxenda and Wegovy, which the FDA approved for ...